EU regulators have delayed a decision to approve Novavax’s variant-tailored COVID-19 vaccine.
The European Medicines Agency (EMA) , which was due to approve the updated jab last Friday, instead requested more information.
Source: https://www.ft.com/content/2e10b2ab-7d0c-48a3-b49b-8de8dc302c6d